ArticleJAAD case reports2020
Generalized granuloma annulare: A widespread response to limited application of compounded 2% topical tofacitinib.
Article in JAAD case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Treatment of Generalized Granuloma Annulare with JAK Inhibitors: Systematic Review.Clinical, cosmetic and investigational dermatology · 2026Review
- Molecularly Targeted Therapies for Inflammatory Cutaneous Granulomatous Disorders: A Review of the Evidence and Implications for Understanding Disease Pathogenesis.JID innovations : skin science from molecules to population health · 2023Review
- Treatment of granuloma annulare with tofacitinib.The Australasian journal of dermatology · 2022Article
- Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options.American journal of clinical dermatology · 2022Review
- Treatment of Generalized Granuloma Annulare with Oral Griseofulvin.Case reports in dermatological medicine · 2022Article
- Treatment of cutaneous sarcoidosis with tofacitinib 2% ointment and extra virgin olive oil.JAAD case reports · 2021Article
- Improvement of granulomatous skin conditions with tofacitinib in three patients: A case report.SAGE open medical case reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.